News

The company is granting researchers free use of cloud-based Galactic AI technology while the COVID-19 pandemic continues to impact labs worldwide. Biorelate has announced it is offering scientists around the world access to its Galactic cloud-based artificial intelligence (AI) Tool....

Cobra Biologics, part of the Cognate BioServices family, an international CDMO for biologics and pharmaceuticals, announced it has signed a supply agreement with AstraZeneca UK Ltd. to provide GMP manufacture of the adenovirus vector-based COVID-19 vaccine candidate AZD1222, previously...

San Diego-based Neurocrine Biosciences is partnering with Japan’s Takeda Pharmaceutical to develop and commercialize molecules in Takeda’s early-to-mid-stage psychiatry pipeline. Takeda granted an exclusive license to Neurocrine for seven pipeline programs, including three clinical stage compounds for schizophrenia, treatment-resistant...

Eli Lilly will assess its JAK1/JAK2 inhibitor Olumiant (baricitinib) as a potential treatment for COVID-19 in a Phase III study. Indianapolis-based Eli Lilly said the latest study will complement an ongoing study of the rheumatoid arthritis drug being conducted in...

Corning Inc. will receive $204 million in federal funding to expand manufacturing of its Corning Valor Glass packaging in order to expand production and aid the fight against COVID-19. The money is coming from the Biomedical Advanced Research and Development...

Mobidiag Ltd. announces that it has received the second tranche of €10M from the €25M growth capital loan signed with the European Investment Bank Group (EIB) in May 2019. These new funds will be used to advance Mobidiag’s research...

Dr. Reddy's Laboratories Ltd announced that it has entered into a non-exclusive Licensing Agreement with Gilead Sciences, Inc. (Gilead)that will grant Dr. Reddy’s the right to register, manufacture and sell Gilead’s investigational drug, Remdesivir, a potential treatment for Covid-19,...